Celgene Corporation - NAI
FDA Inspections Database
Celgene Corporation - NAI
FDA Inspections Database
U.S. FDA inspection classifications and citation records from the official FDA inspection database.
- Total Records 14
- Latest Inspection 2024-09-06
- Data Source U.S. FDA
- Last Updated 2024-12-12
Company Overview
Social Profiles
Company Snapshot
FDA Inspections Timeline (14 records)
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2024-09-06
FMD Date
2024-12-12
Fiscal Year
2024
State
New Jersey
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2024
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2024-01-31
FMD Date
2024-03-07
Fiscal Year
2024
State
New Jersey
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2024
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2022-03-14
FMD Date
2022-06-07
Fiscal Year
2022
State
New Jersey
Additional Details
Sponsor, Contract Research Organization
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2022
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2020-06-03
FMD Date
2021-01-13
Fiscal Year
2020
State
New Jersey
Additional Details
Sponsor, Contract Research Organization
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2020
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Biologics
Posted Citations
No
Inspection End Date
2019-07-26
FMD Date
2019-12-30
Fiscal Year
2019
State
New Jersey
Additional Details
Sponsor, Contract Research Organization
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2019
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2019-07-26
FMD Date
2019-12-30
Fiscal Year
2019
State
New Jersey
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2019
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2018-06-27
FMD Date
-
Fiscal Year
2018
State
New Jersey
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2018
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2017-03-17
FMD Date
-
Fiscal Year
2017
State
New Jersey
Additional Details
Sponsor, Contract Research Organization
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2017
Citations: No
Legal Name
Celgene Corporation
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-04-29
FMD Date
-
Fiscal Year
2014
State
New Jersey
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-04-28
FMD Date
-
Fiscal Year
2014
State
New Jersey
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Berkeley Heights, New Jersey, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
Celgene Corporation
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-04-28
FMD Date
-
Fiscal Year
2014
State
New Jersey
Location
Berkeley Heights, New Jersey, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2013-08-07
FMD Date
-
Fiscal Year
2013
State
New Jersey
Additional Details
Sponsor, Contract Research Organization
Location
Warren, New Jersey, United States
Inspection Info
Fiscal Year: 2013
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-07-30
FMD Date
-
Fiscal Year
2012
State
New Jersey
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
Celgene Corporation
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2011-06-17
FMD Date
-
Fiscal Year
2011
State
New Jersey
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2011
Citations: No
Classification Breakdown
14 total- NAI (No Action Indicated)
Official Source
All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.
Visit FDA.govRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Location
Summit, New Jersey, United States
Inspection Info
Fiscal Year: 2024
Citations: No
100% Official Data
Directly from the U.S. FDA inspection database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.